Antiplatelet therapy and atherosclerotic events.  Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease.
Pignone
Michael
M
Mulrow
Cynthia
C
D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000517:prevention & control*; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors
D010975:Platelet Aggregation Inhibitors; D001241:Aspirin